WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva2021.

Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, et al. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. J Acquir Immune Defic Syndr. 2013;64(2):174–82.

Article  CAS  PubMed  Google Scholar 

Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, et al. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis. Gastroenterology. 2019;156(3):635–46. e9.

Article  CAS  PubMed  Google Scholar 

Vinikoor MJ, Hamusonde K, Muula G, Asombang M, Riebensahm C, Chitundu H, et al. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia. Clin Infect Dis. 2024;78(6):1583–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strassl R, Reiberger T, Honsig C, Payer BA, Mandorfer M, Grabmeier-Pfistershammer K, et al. Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients. J Viral Hepat. 2014;21(7):508–16.

Article  CAS  PubMed  Google Scholar 

Matthews GV, Ali RJ, Avihingsanon A, Amin J, Hammond R, Bowden S, et al. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals. PLoS ONE. 2013;8(4):e61297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, et al. Slow CD4(+) T-cell recovery in human immunodeficiency virus/hepatitis B virus-coinfected patients initiating Truvada-based combination antiretroviral therapy in Botswana. Open Forum Infectious Diseases. 2016;3(3):ofw140.

Article  PubMed  PubMed Central  Google Scholar 

Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22(1):19–32.

Article  CAS  PubMed  Google Scholar 

European Association for the Study of the L. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2025;83(2):502–83.

Article  Google Scholar 

Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003;23(1):47–58.

Article  PubMed  Google Scholar 

Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med. 2004;350(11):1118–29.

Article  CAS  PubMed  Google Scholar 

Marrapu S, Soni JR, Kamal K, Kumar R. Hepatitis B functional cure: current and future perspective. World J Hepatol. 2025;17(10):110107.

Article  PubMed  PubMed Central  Google Scholar 

Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52.

Article  CAS  PubMed  Google Scholar 

Yates KB, Tonnerre P, Martin GE, Gerdemann U, Al Abosy R, Comstock DE, et al. Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans. Nat Immunol. 2021;22(8):1020–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tonnerre P, Wolski D, Subudhi S, Aljabban J, Hoogeveen RC, Damasio M, et al. Differentiation of exhausted CD8(+) T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory. Nat Immunol. 2021;22(8):1030–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004;127(3):924–36.

Article  CAS  PubMed  Google Scholar 

Zhang X, Wang X, Wu M, Ghildyal R, Yuan Z. Animal models for the study of hepatitis B virus pathobiology and immunity: past, present, and future. Front Microbiol. 2021;12:715450.

Article  PubMed  PubMed Central  Google Scholar 

Boyd MA, van Bockel D, Munier CML, Kelleher AD. Navigating the complexity of chronic HIV-1 associated immune dysregulation. Curr Opin Immunol. 2022;76:102186.

Article  CAS  PubMed  Google Scholar 

Gehring AJ, Mendez P, Richter K, Ertl H, Donaldson EF, Mishra P, et al. Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection. J Hepatol. 2022;77(2):525–38.

Article  CAS  PubMed  Google Scholar 

Hoogeveen RC, Dijkstra S, Bartsch LM, Drescher H, Aneja J, Robidoux MP, et al. Hepatitis B virus-specific CD4 T-cell responses differentiate functional cure from chronic surface antigen(+) infection. J Hepatol. 2022;77(5):1276–1286. https://doi.org/10.1016/j.jhep.2022.05.041.

Article  PubMed  Google Scholar 

Hoogeveen RC, Robidoux MP, Schwarz T, Heydmann L, Cheney JA, Kvistad D, et al. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. Gut. 2019;68(5):893–904.

Article  CAS  PubMed  Google Scholar 

Schuch A, Salimi Alizei E, Heim K, Wieland D, Kiraithe MM, Kemming J, et al. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8 + T cells in chronically HBV-infected patients with low viral load. Gut. 2019;68(5):905–915. https://doi.org/10.1136/gutjnl-2018-316641.

Article  PubMed  Google Scholar 

Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, et al. Reduced hepatitis B virus (HBV)-specific CD4 + T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J Virol. 2005;79(5):3038–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heim K, Sagar, Sogukpinar O, Llewellyn-Lacey S, Price DA, Emmerich F, et al. Attenuated effector T cells are linked to control of chronic HBV infection. Nat Immunol. 2024;25(9):1650–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Y, Zhu YO, Becht E, Aw P, Chen J, Poidinger M, et al. Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection. Sci Immunol. 2019;4(32):eaau6905. https://doi.org/10.1126/sciimmunol.aau6905.

Article  PubMed  PubMed Central  Google Scholar 

Boeijen LL, Hoogeveen RC, Boonstra A, Lauer GM. Hepatitis B virus infection and the immune response: the big questions. Best Pract Res Clin Gastroenterol. 2017;31(3):265–72.

Article  CAS  PubMed  Google Scholar 

Torres-Cornejo A, Lauer GM. Hurdles to the development of effective HBV immunotherapies and HCV vaccines. Pathog Immun. 2017;2(1):102–25.

Article  PubMed  PubMed Central  Google Scholar 

Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 2003;77(1):68–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol. 1990;145(10):3442–9.

Article  CAS  PubMed  Google Scholar 

Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest. 1996;97(7):1655–65.

Article  CAS  PubMed  PubMed Central  Google Scholar